-- Preview Email Newsletter
| U.S. Congressional Tipoffs Involving Kentucky Newsletter for 2024-07-24 ( 5 items ) |
|
Hearing Wrap Up: Oversight Committee Exposes How PBMs Undermine Patient Health and Increase Drug Costs (10)
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, the House Committee on Oversight and Accountability held a hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." At the hearing, Republicans and Democrats pressed Pharmacy Benefit Manager (PBM) chief executives on their role in rising prescription drug costs. Lawmakers exposed how PBMs have collaborat more PR
House Oversight Committee Chairman Comer Issues Statement on Secret Service Director Cheatle Resignation (10)
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued the following statement after U.S. Secret Service Director Kimberly Cheatle announced her resignation:
"The Oversight Committee's hearing resulted in Director Cheatle's resignation and there will be more accountability to come. The Secret Service has a no-fail mission yet it failed historically o more PR
House Oversight Committee Chairman Comer Releases Report on PBMs Harmful Pricing Tactics & Role in Rising Health Care Costs (10)
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) issued a report outlining how the three largest Pharmacy Benefit Managers (PBMs) --CVS Caremark, Express Scripts, and OptumRx--have monopolized the pharmaceutical marketplace by deploying deliberate, anticompetitive pricing tactics that are raising prescription drug prices, undermining community p more PR
House Oversight Committee Chairman Comer: Pharmacy Benefit Managers Must Be Held Accountable for Role in Rising Drug Prices (10)
WASHINGTON, July 24 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release on July 23, 2024:
Today, House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) delivered opening remarks at a full committee hearing titled "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability." In his opening statement, Chairman Comer detailed how the House Oversight Committee has obtained over 140,000 pages of docume more PR
House Oversight Subcommittee on Government Operations Chairman Sessions: Transparency & Efficiency Within CIGIE is Critical to Supporting Inspector General Offices (10)
WASHINGTON, July 24 -- Rep. Pete Sessions, R-Kentucky, chairman of the House Oversight and Accountability Subcommittee on Government Operations and the Federal Workforce, issued the following news release on July 23, 2024:
Subcommittee on Government Operations and the Federal Workforce Chairman Pete Sessions (R-Texas) today delivered opening remarks at a hearing titled "Oversight of the Council of the Inspectors General on Integrity and Efficiency." Chairman Sessions discussed the Subcommittee's goal to examine CIGIE's legislative priorities, more PR
|